| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 139.06B | 148.33B | 139.58B | 166.14B | 181.01B | 154.41B |
| Gross Profit | 18.51B | 20.88B | 18.68B | 21.36B | 22.64B | 18.47B |
| EBITDA | 3.60B | 4.06B | 3.98B | 6.64B | 8.03B | 5.11B |
| Net Income | 2.08B | 3.27B | 2.44B | 5.01B | 5.49B | 3.58B |
Balance Sheet | ||||||
| Total Assets | 90.58B | 101.39B | 93.08B | 98.71B | 106.58B | 93.08B |
| Cash, Cash Equivalents and Short-Term Investments | 21.84B | 24.59B | 23.37B | 19.08B | 14.14B | 14.05B |
| Total Debt | 8.80B | 8.06B | 8.78B | 12.31B | 9.91B | 8.05B |
| Total Liabilities | 43.36B | 48.26B | 43.96B | 50.74B | 62.09B | 55.05B |
| Stockholders Equity | 47.22B | 52.86B | 49.11B | 47.97B | 44.48B | 38.02B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.63B | 9.04B | 4.11B | -619.00M | 609.00M |
| Operating Cash Flow | 0.00 | 3.76B | 9.10B | 4.23B | -545.00M | 792.00M |
| Investing Cash Flow | 0.00 | -463.00M | -389.00M | 883.00M | -731.00M | 244.00M |
| Financing Cash Flow | 0.00 | -2.88B | -5.22B | -608.00M | 906.00M | -580.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥202.85B | 5.88 | 17.09% | 2.94% | 20.29% | 94.13% | |
72 Outperform | ¥55.32B | 14.67 | ― | 4.12% | 6.27% | 31.76% | |
67 Neutral | ¥21.59B | 15.35 | ― | 3.83% | 21.81% | -49.75% | |
64 Neutral | ¥40.20B | 8.77 | ― | 5.16% | 1.23% | -22.74% | |
62 Neutral | ¥13.10B | 9.34 | ― | 4.62% | -0.44% | -13.10% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥47.44B | 32.39 | 1.55% | 1.34% | -14.56% | 181.24% |